IRIS
LENCI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.241
AS - Asia 592
EU - Europa 566
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
AF - Africa 2
OC - Oceania 1
Totale 7.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.233
SG - Singapore 370
IE - Irlanda 154
IT - Italia 118
CN - Cina 99
RU - Federazione Russa 82
KR - Corea 75
DE - Germania 57
GB - Regno Unito 54
UA - Ucraina 22
FI - Finlandia 16
SE - Svezia 16
FR - Francia 14
BE - Belgio 12
CZ - Repubblica Ceca 11
HK - Hong Kong 10
IN - India 9
CA - Canada 7
PK - Pakistan 6
EU - Europa 4
QA - Qatar 4
TM - Turkmenistan 4
VN - Vietnam 4
BR - Brasile 3
IR - Iran 3
EG - Egitto 2
JP - Giappone 2
LT - Lituania 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
KW - Kuwait 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
SV - El Salvador 1
Totale 7.411
Salva come PNG Salva come JPEG
Città #
Wilmington 1.912
Houston 1.569
Woodbridge 520
Fairfield 369
Singapore 333
Chandler 321
Ashburn 189
Dublin 134
Seattle 116
Cambridge 115
Medford 105
New York 100
Ann Arbor 91
Santa Clara 73
Rome 53
Lawrence 48
Beijing 40
San Diego 30
Menlo Park 26
Munich 22
Seoul 22
Dearborn 21
Palo Alto 18
Creede 14
Engelhard 14
London 14
Moscow 14
Brussels 12
Helsinki 11
Jacksonville 11
Washington 11
Redwood City 10
Boardman 9
Colorado Springs 9
Hefei 8
Shanghai 8
Brno 7
Council Bluffs 7
Hangzhou 7
Los Angeles 7
Nanjing 7
Hong Kong 6
Hounslow 6
Miami 6
Toronto 6
Lahore 5
Milan 5
Nuremberg 5
St. George 5
Cagliari 4
Cassino 4
Doha 4
Dong Ket 4
Islington 4
Kilburn 4
La Veta 4
Norwalk 4
Bloomfield 3
Guangzhou 3
Las Vegas 3
Mountain View 3
Nanchang 3
Olomouc 3
Zhengzhou 3
Central 2
Chateaugiron 2
Chiswick 2
Clearwater 2
Esslingen am Neckar 2
Falls Church 2
Fremont 2
Guidonia Montecelio 2
Hanover 2
Jinan 2
Lappeenranta 2
Saint Petersburg 2
San Mateo 2
Shenyang 2
Southwark 2
São Paulo 2
Taipei 2
Tappahannock 2
The Dalles 2
Tianjin 2
Turin 2
Xuzhou 2
Adliswil 1
Amsterdam 1
Ariano Irpino 1
Athens 1
Bangalore 1
Basra 1
Changchun 1
Chaoyang 1
Frankfurt am Main 1
Fuyang 1
Genzano di Roma 1
Georgetown 1
Gunzenhausen 1
Haifa 1
Totale 6.562
Salva come PNG Salva come JPEG
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 446
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 374
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 366
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 303
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study 300
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 287
An unusual duodenal polyp causing anemia in a liver-transplanted patient 282
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 282
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 261
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension 260
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 249
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 237
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 232
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 230
Dual role of bile acids on the biliary epithelium: Friend or foe? 193
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 185
Platelets and hepatocellular cancer: Bridging the bench to the clinics 167
Liver transplantation for hepatocellular carcinoma: Where do we stand? 161
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 158
Domino liver transplantation: Where are we now? 157
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 156
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 150
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 144
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 142
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 120
Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient 99
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 98
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 94
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 83
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 72
Natremia and liver transplantation: The right amount of salt for a good recipe 68
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 67
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 61
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 59
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 55
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 48
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 48
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 47
COVID-19 in normal, diseased and transplanted liver 43
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development 43
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 39
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 39
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 39
Chronic rejection after liver transplantation: Opening the Pandora's box 38
Moving forward in the treatment of cholangiocarcinoma 37
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 34
New strategies on management of hepatitis b virus after liver transplantation: complete and sustained weaning of hbv prophylaxis in a selected cohort of patients transplanted due to hbv-related cirrhosis 34
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 34
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 33
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 31
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 29
Towards tolerance in liver transplantation 29
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 28
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 27
Use of intravascular ultrasound to improve diagnosis and treatment of transjugular intrahepatic portosystemic shunt dysfunction in patients in the long-term follow-up 26
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 25
Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report 25
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 24
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 24
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 24
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 23
Secondary bile acids and the biliary epithelia: The good and the bad 23
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 23
null 22
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 21
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 21
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 16
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 15
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 13
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 12
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 12
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 12
Sequence of events leading to primary biliary cholangitis 12
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 12
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 12
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 6
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 1
Totale 7.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.486 0 0 0 0 122 154 189 156 230 233 193 209
2020/20211.884 194 198 189 196 205 273 252 212 27 81 30 27
2021/2022606 28 62 18 27 9 72 46 24 71 60 38 151
2022/2023805 75 79 46 88 80 156 72 72 73 11 32 21
2023/2024490 60 16 43 13 65 138 12 15 14 54 4 56
2024/2025749 57 353 206 107 26 0 0 0 0 0 0 0
Totale 7.702